[1] |
Poon R T, Fan S, Ng I O, et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer, 2015, 89:500-507.
|
[2] |
Chen X X, Cheng J W, Huang A, et al. The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis.Oncotargets Ther, 2017,10:5363-5375.
|
[3] |
丛文铭, 步宏, 陈杰,等. 原发性肝癌规范化病理诊断指南(2015年版). 解放军医学杂志, 2015, 21:833-839.
|
[4] |
中华医学会传染病与寄生虫病学分会, 肝病学分会. 病毒性肝炎防治方案. 中华内科杂志, 2001,40:62-68.
|
[5] |
Liu S, Xie J, Yin J, et al. A matched case-control study of hepatitis B virus mutations in the preS and core promoter regions associated independently with hepatocellular carcinoma. J Med Virol, 2015, 83:45-53.
|
[6] |
施海燕, 李丽雅, 何浩岚,等. HBV前C/C基因启动子区变异与HBeAg阳性慢性乙型肝炎肝纤维化程度的关系. 临床肝胆病杂志, 2018, 34:115-119.
|
[7] |
韩少静, 郭永泽, 李帆,等. EGFR与慢性肝病、原发性肝癌的相关性. 肝脏, 2018, 23:91-92,100.
|